OOIR: Observatory of International Research

Papers

(The H4-Index of Medicinal Research Reviews is 38. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-08-01 to 2026-08-01.)

Article	Citations
	257
	236
Key characters of glycodrugs	208
Nanotechnology‐based electrochemical biosensors for monitoring breast cancer biomarkers	186
Accelerating Small Molecule Ferroptosis Regulator Development With Advances in Biological Functions	163
In Memoriam: Professor Minyong Li (1976–2025)	135
Design, synthesis, and applications of ring‐functionalized histidines in peptide‐based medicinal chemistry and drug discovery	125
Hydroxamic Acids as HDAC Inhibitor Drug Leads for Malaria	123
Decoding Gene Expression Changes in Cerebral Tumors: Before and After Radiotherapy	104
Galectin‐8 inhibition and functions in immune response and tumor biology	103
Indirect influence on the BDNF/TrkB receptor signaling pathway via GPCRs, an emerging strategy in the treatment of neurodegenerative disorders	103
The role and prospect of lysine‐specific demethylases in cancer chemoresistance	99
Next generation of boron neutron capture therapy (BNCT) agents for cancer treatment	96
New drug approvals for 2022: Synthesis and clinical applications	89
Multi‐Targeting Ligands as Prospective Therapeutics for Alzheimer's Disease, a Prevalent Neurodegenerative Disorder: Mechanistic Insights, Emerging Targets and Drug Discovery Campaigns	89
Front Cover Image, Volume 45, Issue 1	82
	78
Pathophysiological significance and modulation of the transient receptor potential canonical 3 ion channel	73
Issue Information	71
Metal complexes bearing EGFR‐inhibiting ligands as promising anticancer agents	65
Current and emerging approaches to noncompetitive AR inhibition	61
A Focus on Natural Autophagy Modulators as Potential Host‐Directed Weapons Against Emerging and Re‐Emerging Viruses	50
Targeting Histone H3K9 Methyltransferase G9a as a Potential Therapeutic Strategy for Neuropsychiatric Disorders	49
Rethinking therapeutic strategies of dual‐target drugs: An update on pharmacological small‐molecule compounds in cancer	48
α‐Synuclein in Parkinson's Disease: From Bench to Bedside	48

Enhancing healthy aging with small molecules: A mitochondrial perspective	47
Mechanism and application of β‐adrenoceptor blockers in soft tissue wound healing	47
Targeting lysosomal quality control as a therapeutic strategy against aging and diseases	47
A Possibility of Synthetic Lethality: Wee1 Kinase as a Promising Treating Target for Cancer	41
An overview of sphingosine‐1‐phosphate receptor 2: Structure, biological function, and small‐molecule modulators	40
Current nanocomposite advances for biomedical and environmental application diversity	40
Polymer nanotherapeutics: A promising approach toward microglial inhibition in neurodegenerative diseases	40
Redefining CHI3L1: Therapeutic Opportunities at the Crossroads of Immune Suppression and Disease Progression	40
Mitochondrial quality control proteases and their modulation for cancer therapy	39
Issue Information	39
Emerging roles of nerve‐bone axis in modulating skeletal system	39
Smart Integration of Structural Biology and Medicinal Chemistry to Unlock Target‐Driven Drug Discovery	39
Novel druggable mechanism of Parkinson's disease: Potential therapeutics and underlying pathogenesis based on ferroptosis	38